Tikun Therapeutics
Pre-clinicalA commitment to rapid drug development and community focus for ultra-rare progressive genetic autonomic nervous system disease Familial Dysautonomia
Founded
2018
Focus
Small Molecules
About
A commitment to rapid drug development and community focus for ultra-rare progressive genetic autonomic nervous system disease Familial Dysautonomia
Funding History
1Total raised: $27.5M
Series A$27.5MCannbit PharmaceuticalsJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationNew York, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile